The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, tolerability, and antitumor activity of once-daily Wee-1 inhibitor AZD1775.
 
Naoko Takebe
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Shivaani Kummar
Consulting or Advisory Role - Corvus Pharmaceuticals; MedTree (I); Nodus Therapeutics
Research Funding - ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Dynavax Technologies (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Pfizer (Inst); Plexxikon (Inst)
 
Khanh Tu Do
Research Funding - Lilly (Inst)
 
Ashley Bruns
No Relationships to Disclose
 
Lamin Juwara
No Relationships to Disclose
 
Mary Flanagan Quinn
No Relationships to Disclose
 
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare
 
Richard Piekarz
No Relationships to Disclose
 
Sheila Ann Prindiville
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Howard Streicher
No Relationships to Disclose
 
Ganesh Mugundu
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jiuping Jay Ji
No Relationships to Disclose
 
Deborah Wilsker
No Relationships to Disclose
 
Robert J. Kinders
No Relationships to Disclose
 
Larry Rubinstein
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose